FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

111134000: Oxetacaine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2153813010 Oxetacaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2154820013 Oxethazaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3482733018 Oxetacaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
368241000195113 oxetacaina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
830131000172113 oxétacaïne fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
399021000274115 Oxetacain de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxetacaine Is a Amide type local anesthetic false Inferred relationship Some
Oxetacaine Is a Amide type local anesthetic false Inferred relationship Some
Oxetacaine Is a Amide and/or amide derivative (substance) false Inferred relationship Some
Oxetacaine Is a Local anesthetic (substance) false Inferred relationship Some
Oxetacaine Is a Amide local anesthetic (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing aluminium oxide and magnesium hydroxide and oxetacaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Product containing oxetacaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Aluminium oxide and magnesium hydroxide and oxetacaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Oxetacaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxetacaine Inferred relationship Some 1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxetacaine Inferred relationship Some 1
Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1
Product containing aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oxetacaine Inferred relationship Some 1

This concept is not in any reference sets

Back to Start